Mechanism of Formononetin in Improving Energy Metabolism and Alleviating Neuronal Injury in CIRI Based on Nontargeted Metabolomics Research
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Jianwen Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine, Cangzhou, China. Hauptthemen laut MEDLINE: Metabolomics, Isoflavones, Energy Metabolism, Reperfusion Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Three-Three-Three Talent Project of Hebei Province, Research Plan Project of Hebei Provincial Administration of Traditional Chinese Medicine, Hebei Provincial Science and Technology (Key Research and Development) Plan Project.
Abstract (Originalsprache)
Cerebral ischaemia–reperfusion injury (CIRI), resulting from thrombolytic therapy for ischaemic stroke, presents a considerable challenge during postoperative recovery. Formononetin (FMN) has shown promise in the prevention and treatment of neurological diseases. However, its specific mechanism in ameliorating CIRI remains uncertain. Initially, we established a CIRI rat model to evaluate FMN's therapeutic potential by assessing neurological function, infarct area and pathological changes. Subsequently, we employed metabolomics technology to investigate FMN's impact on metabolite levels in the ischaemic brain tissue of CIRI rats. Based on the metabolomics findings, we validated FMN's effects on nicotinate and nicotinamide metabolism, as well as alanine, aspartate and glutamate metabolism, along with its influence on neuronal injury and repair. Our investigation unveiled that FMN intervention significantly diminished the Longa score and asymmetry score in CIRI rats, constricted the infarct area and ameliorated pathological alterations in the ischaemic brain tissue, including reduced DCI index and augmented Nissl body count. Metabolomics analysis indicated that FMN exerted regulatory effects on nicotinate and nicotinamide metabolism, as well as alanine, aspartate and glutamate metabolism. Following FMN intervention, there was a notable increase in the levels of related metabolites such as nicotinamide (NAM), L‐aspartic acid (L‐Asp), fumaric acid (FA), gamma‐aminobutyric acid (GABA) and L‐glutamic acid (L‐Glu). RT‐qPCR and Western blot outcomes demonstrated that FMN upregulated the gene and protein expression of key enzymes adenylosuccinate lyase (ADSL) and glutamic acid decarboxylase (GAD) involved in alanine, aspartate and glutamate metabolism. Moreover, FMN intervention bolstered SOD activity, diminished MDA and ROS levels and reduced TUNEL‐positive expression. Furthermore, FMN intervention elevated ATP levels and markedly increased Ki67‐positive expression. FMN exhibits the potential to alleviate oxidative stress injury in CIRI rats by enhancing nicotinate and nicotinamide metabolism along with alanine, aspartate and glutamate metabolism, consequently reinstating energy metabolism and conferring neuroprotective effects to ameliorate CIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine, Cangzhou, China.
- Hebei Province Key Laboratory of Integrated Traditional and Western Medicine in Neurological Rehabilitation, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Cangzhou, China.
- Graduate School, Chengde Medical University, Chengde, China.
- Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, China.
- First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China.
- Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, China.
ORCID-Profile: Huantian Cui
Förderung
- This work was supported by the Three-Three-Three Talent Project of Hebei Province
- Research Plan Project of Hebei Provincial Administration of Traditional Chinese Medicine
- Hebei Provincial Science and Technology (Key Research and Development) Plan Project
Zitieren
APA
Zhao, J., Zhang, Y., Lv, S., Wang, F., Shan, T., Wang, J., Liu, Z., Zhang, L., Cui, H., & Tian, J. (2025). Mechanism of Formononetin in Improving Energy Metabolism and Alleviating Neuronal Injury in CIRI Based on Nontargeted Metabolomics Research. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70340
Vancouver
Zhao J, Zhang Y, Lv S, Wang F, Shan T, Wang J, et al. Mechanism of Formononetin in Improving Energy Metabolism and Alleviating Neuronal Injury in CIRI Based on Nontargeted Metabolomics Research. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70340
BibTeX
@article{Zhao2025,
author = {Zhao, Jianwen and Zhang, Yanwei and Lv, Shuquan and Wang, Feng and Shan, Ting and Wang, Jian and Liu, Zeng and Zhang, Limin and Cui, Huantian and Tian, Junbiao},
title = {Mechanism of Formononetin in Improving Energy Metabolism and Alleviating Neuronal Injury in CIRI Based on Nontargeted Metabolomics Research},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70340}
}
EUVIMED